Today's After-Hours Stock Movers

InnerWorkings (NASDAQ: INWK) 39% HIGHER; reported Q1 EPS of $0.04, $0.04 better than the analyst estimate of $0.00. Revenue for the quarter came in at $261.4 million versus the consensus estimate of $267.98 million.

miRagen Therapeutics, Inc. (NASDAQ: MGEN) 37% HIGHER; scheduled to host a key opinion leaders (KOL) call regarding idiopathic pulmonary fibrosis (IPF) on Tuesday, June 23rd at 11 a.m. Eastern Time. The Company will also discuss encouraging new preclinical safety and efficacy data for its MRG-229 being developed for the treatment of IPF during the call.

Actinium Pharmaceuticals, Inc. (NYSE: ATNM) 20% LOWER; announced that it intends to offer and sell shares of its common stock (or common stock equivalents in lieu thereof) in a public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Volt Solar Systems, Inc. (NYSE: VOLT) 13.6% LOWER; reported Q2 EPS of ($0.25), $0.16 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $207.3 million versus the consensus estimate of $209.5 million.

Fulgent Genetics, Inc. (NASDAQ: FLGT) 12.1% HIGHER; announced that it has launched an at-home testing solution for the Coronavirus Disease (COVID-19). The company has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for use in the United States.

Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) 8.9% LOWER; announced an extension of its previously announced suspension of global cruise voyages to include all voyages embarking between August 1 and September 30, 2020 for its three cruise brands. The voyage cancellations exclude September Seattle-based Alaska voyages. The Company is also cancelling select voyages through October 2020, including Canada and New England sailings, due to travel and port restrictions. The Company will continue to work in tandem with the U.S. Centers for Disease Control and Prevention (CDC), the federal government and global public health authorities to take all necessary precautions to ensure the health, safety and security of guests, crew and the communities visited.

GAN Limited (NASDAQ: GAN) 8.8% LOWER; reported Q1 EPS of $0.01, $0.03 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $7.7 million versus the consensus estimate of $8.09 million.

Carnival Corporation & Plc (NYSE: CCL) 6.9% LOWER; down in sympathy with NCLH

Provention Bio, Inc., (NASDAQ: PRVB) 6.2% LOWER; announced that it has commenced an underwritten public offering of 5,500,000 shares of its common stock. All of the shares to be sold in the offering are to be sold by Provention Bio

Groupon (NASDAQ: GRPN) 5.4% HIGHER; reported Q1 EPS of ($1.63), $0.28 better than the analyst estimate of ($1.91). Revenue for the quarter came in at $374.2 million versus the consensus estimate of $369.14 million.

Amarin Corporation plc (NASDAQ: AMRN) 4.5% HIGHER; announced today a settlement agreement with Apotex Inc. (Apotex) that resolves patent litigation that would have resulted from the previously disclosed abbreviated new drug application (ANDA) filed by Apotex with U.S. Food and Drug Administration (FDA) and amended in May 2020 seeking approval of a generic form of VASCEPA® (icosapent ethyl) capsules based on the MARINE study.

Royal Caribbean Cruises Ltd. (NYSE: RCL) 4% LOWER; down in sympathy with NCLH

Oracle (NYSE: ORCL) 4% LOWER; reported Q4 EPS of $1.20, $0.04 better than the analyst estimate of $1.16. Revenue for the quarter came in at $10.4 billion versus the consensus estimate of $10.67 billion.

Chegg, Inc. (NYSE: CHGG) 2.6% HIGHER; announced its board of directors has authorized the repurchase of up to $500 million of Chegg’s common stock and/or convertible notes, through open market purchases, block trades and/or in privately negotiated transactions or pursuant to Rule 10b5-1 plans, in compliance with applicable securities laws and other legal requirement.

Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS) 2% HIGHER; announced today that the Kratos Defense & Rocket Support Services (KDRSS) Division has been awarded a $46 million Other Transaction for Prototype Agreement (pOTA) to support the U.S. Army Rapid Capabilities and Critical Technologies Office (RCCTO). The new award has a three year period of performance.

H&R Block (NYSE: HRB) 1.2% HIGHER; reported Q4 EPS of $3.01, $0.40 better than the analyst estimate of $2.61. Revenue for the quarter came in at $1.81 billion versus the consensus estimate of $1.74 billion.